Linden Thomas Advisory Services LLC Acquires 138 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Linden Thomas Advisory Services LLC increased its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,533 shares of the company’s stock after buying an additional 138 shares during the period. […]

Related Keywords

Neurocrine Biosciences ,Jude Onyia ,Davidw Boyer ,Linden Thomas Advisory Services ,Financial Services Group Inc ,Cantor Fitzgerald ,Dimensional Fund Advisors ,Securities Exchange Commission ,Neurocrine Biosciences Inc ,Exchange Commission ,Hightower Advisors ,Nasdaq ,Jpmorgan Chase Co ,Rice Hall James Associates ,Acadian Asset Management ,Free Report ,Thomas Advisory Services ,Hall James ,Tower Advisors ,Services Group ,Asset Management ,Fund Advisors ,Get Free Report ,Visit Holdingschannel ,Neurocrine Biosciences Daily ,Nasdaq Nbix ,Nbix ,Medical ,64125c10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,